Written by James Whitfield, CSCS, Exercise Physiologist & Performance Researcher
Medically reviewed by Dr. Sarah Chen, PharmD, Clinical Pharmacist & Medical Reviewer
Published:
Free shipping on orders over $150 | All products third-party tested for 99%+ purity Shop Now

Compare Hims vs Found for weight loss: pricing ($79 vs $149+), medications, coaching support, and doctor oversight. Find the right GLP-1 program for you.
Written by James Whitfield, CSCS, Exercise Physiologist & Performance Researcher
Medically reviewed by Dr. Sarah Chen, PharmD, Clinical Pharmacist & Medical Reviewer
Published:
Choosing between Hims and Found for weight loss treatment comes down to your priorities: Hims offers broader medication access with telehealth convenience, while Found provides more comprehensive coaching support alongside GLP-1 medications. Both platforms connect you with licensed physicians and deliver FDA-approved treatments, but they take distinctly different approaches to weight management support.
This comparison examines pricing, medication options, doctor oversight, and patient experience to help you determine which platform aligns with your weight loss goals. We'll analyze real costs, available treatments, and the level of ongoing support each service provides based on current offerings and verified patient experiences.
| Factor | Hims | Found |
| Starting Price | $79/month | $149/month |
| Primary Focus | Medication access | Coaching + medication |
| GLP-1 Options | Semaglutide, tirzepatide | Semaglutide, tirzepatide |
| Coaching Support | Basic app tracking | Dedicated health coach |
| Best For | Self-directed patients | Comprehensive support seekers |
Hims positions itself as a simplified telehealth platform that removes barriers to weight loss medication access. The service connects patients with licensed physicians through a digital consultation process, focusing primarily on medication management rather than comprehensive lifestyle coaching.
The platform offers two main weight loss medication options: compounded semaglutide starting at $79 per month and compounded tirzepatide at $199 per month. These prices include the medication, physician consultation, and basic digital support tools through the Hims app. The consultation process takes approximately 15 minutes and can be completed entirely online without video calls.
Hims sources its GLP-1 medications from FDA-registered compounding pharmacies, which allows them to offer lower pricing compared to brand-name versions like Ozempic or Mounjaro. The compounded formulations contain the same active ingredients as their brand-name counterparts but are prepared in specialized pharmacy facilities rather than manufactured by pharmaceutical companies.
Shipping typically takes 3-5 business days via temperature-controlled packaging to ensure medication stability. The platform includes injection supplies, alcohol swabs, and detailed administration instructions with each shipment. Patients receive their medication in pre-filled syringes or vials depending on their prescribed dosage.
The Hims app provides basic tracking features including weight logging, progress photos, and medication reminders. However, the platform does not include dedicated health coaching, nutritional counseling, or behavioral support programs. Patient support is primarily handled through customer service representatives rather than licensed healthcare professionals.
Hims Pros:
Hims Cons:
Found takes a comprehensive approach to weight loss that combines GLP-1 medications with dedicated health coaching and behavioral support programs. The platform emphasizes long-term lifestyle changes alongside pharmaceutical intervention, positioning itself as a holistic weight management solution.
Found's pricing structure is more complex than Hims, with plans starting at $149 per month for the coaching program plus separate medication costs that range from $99 to $349 monthly depending on the prescribed treatment. The total monthly cost typically ranges from $248 to $498, making it significantly more expensive than medication-only platforms.
The platform offers both brand-name and compounded versions of semaglutide and tirzepatide. Found works with patients' insurance when possible to reduce medication costs, though many GLP-1 treatments remain uncovered for weight loss indications. The clinical team includes board-certified physicians who specialize in obesity medicine and endocrinology.
Found's signature feature is its dedicated health coaching program. Each patient is assigned a certified health coach who provides weekly check-ins, personalized meal planning, exercise guidance, and behavioral support strategies. The coaching sessions are conducted via phone or video call and focus on sustainable habit formation rather than restrictive dieting approaches.
The Found app integrates with popular fitness trackers and provides comprehensive tracking for weight, measurements, food intake, physical activity, and medication adherence. The platform includes educational content, recipe databases, workout programs, and peer support communities to enhance the weight loss experience.
Medication delivery follows a similar timeline to other telehealth platforms, with 3-7 business days for initial shipments and automatic refills scheduled based on prescription requirements. Found provides injection training videos and offers live support calls for patients who need assistance with medication administration.
Found Pros:
Found Cons:
The cost difference between Hims and Found represents one of the most significant factors in choosing between these platforms. Hims focuses on affordable medication access, while Found's higher pricing reflects its comprehensive support model.
For semaglutide treatment, Hims charges $79 per month total, including medication, consultation, and basic app access. Found's equivalent treatment costs $149 monthly for coaching plus $99-199 for medication, totaling $248-348 per month. This represents a 214-340% price difference for similar medication access.
Tirzepatide pricing shows an even larger gap. Hims offers compounded tirzepatide for $199 monthly, while Found's tirzepatide plans range from $149 coaching plus $297-349 medication, totaling $398-498 monthly. The annual cost difference can exceed $3,000 for tirzepatide treatment.
Found's higher pricing includes services that Hims doesn't provide: dedicated health coaching, comprehensive behavioral support, insurance coordination, and access to obesity medicine specialists. Patients must evaluate whether these additional services justify the substantial cost increase based on their individual needs and preferences.
Both platforms require upfront payment and don't accept insurance for their service fees, though Found assists with insurance claims for medication costs when coverage is available. Neither platform offers refunds for unused portions of monthly subscriptions, making the financial commitment more significant for Found users.
| Treatment | Hims Monthly Cost | Found Monthly Cost | Annual Difference |
| Semaglutide | $79 | $248-348 | $2,028-3,228 |
| Tirzepatide | $199 | $398-498 | $2,388-3,588 |
Both platforms provide access to the two most effective GLP-1 medications for weight loss: semaglutide and tirzepatide. However, their sourcing strategies and medication quality approaches differ significantly, affecting both cost and potential efficacy.
Hims exclusively offers compounded versions of both medications through FDA-registered compounding pharmacies. Compounded semaglutide contains the same active ingredient as Ozempic and Wegovy but is prepared in smaller batches by specialized pharmacies. This approach allows Hims to offer lower pricing but may result in slight variations in potency or stability compared to FDA-approved brand-name versions.
Found provides both compounded and brand-name medication options depending on insurance coverage and patient preference. When insurance covers brand-name medications like Wegovy or Mounjaro, Found coordinates the prescription and prior authorization process. For patients without coverage, Found offers compounded alternatives at reduced costs.
The clinical effectiveness of compounded GLP-1 medications remains a topic of ongoing research. While compounding pharmacies must follow FDA guidelines for preparation and quality control, they are not required to conduct the same extensive clinical trials as pharmaceutical manufacturers. Some patients report differences in side effect profiles or efficacy when switching between compounded and brand-name versions.
Both platforms follow similar dosing protocols, starting patients on low doses and gradually increasing based on tolerance and weight loss response. Hims physicians typically begin semaglutide at 0.25mg weekly and tirzepatide at 2.5mg weekly. Found's obesity medicine specialists may use more individualized dosing strategies based on patient medical history and weight loss goals.
Medication quality assurance varies between the platforms. Hims partners with a limited number of compounding pharmacies and provides basic quality certifications. Found conducts more extensive pharmacy vetting and offers transparency about medication sources, batch testing, and quality control measures.
The level of physician involvement and medical oversight represents a key difference between Hims and Found's approaches to weight loss treatment. Both platforms connect patients with licensed physicians, but the depth of medical supervision varies significantly.
Hims employs a network of licensed physicians who conduct initial consultations and provide ongoing prescription management. The consultation process is primarily text-based through the platform's messaging system, with physicians reviewing patient health questionnaires and medical history to determine treatment eligibility. Follow-up interactions are typically limited to prescription adjustments and basic safety monitoring.
Found's medical team includes board-certified physicians specializing in obesity medicine, endocrinology, and internal medicine. The platform emphasizes physician expertise in weight management and metabolic disorders, with doctors who have specific training in GLP-1 medication management and obesity treatment protocols.
The frequency of medical oversight differs substantially between platforms. Hims patients typically interact with physicians during initial consultation and when requesting prescription changes or reporting side effects. The platform relies on automated systems and customer service representatives for routine questions and basic support.
Found provides more intensive medical supervision with scheduled physician check-ins every 3-6 months and on-demand access for medical questions or concerns. The platform's physicians work closely with health coaches to monitor patient progress and adjust treatment plans based on weight loss response and side effect profiles.
Both platforms require patients to meet basic eligibility criteria for GLP-1 medications, including BMI requirements and absence of contraindicated medical conditions. However, Found's physicians conduct more comprehensive medical evaluations, including review of laboratory results, cardiovascular risk factors, and potential drug interactions.
The quality of medical decision-making may be enhanced by Found's specialized physician network, though Hims' approach may be sufficient for patients with straightforward medical histories who prefer minimal medical oversight. Patients with complex medical conditions or multiple medications may benefit from Found's more intensive physician involvement.
Patient satisfaction data reveals distinct preferences between Hims and Found users, largely correlating with individual expectations and support needs. Both platforms maintain generally positive reviews, though specific satisfaction factors vary significantly.
Hims users frequently praise the platform's simplicity and affordability. Common positive feedback includes quick consultation processes, discreet delivery, and straightforward medication access without insurance complications. Patients who prefer self-directed weight loss approaches often appreciate Hims' minimal intervention model.
However, Hims receives criticism for limited ongoing support and basic app functionality. Some users report feeling abandoned after initial prescription, particularly when experiencing side effects or weight loss plateaus. The lack of nutritional guidance and behavioral support frustrates patients seeking comprehensive weight management assistance.
Found's patient reviews consistently highlight the value of dedicated health coaching and comprehensive support systems. Users report higher satisfaction with long-term weight maintenance and lifestyle behavior changes. The platform's educational resources and community features receive particular praise from patients who benefit from structured guidance.
Found's main criticism centers on cost and complexity. Some patients find the higher pricing prohibitive for long-term use, while others report feeling overwhelmed by the platform's comprehensive approach. Patients preferring simple medication access sometimes view Found's coaching requirements as unnecessary intervention.
Weight loss outcomes appear comparable between platforms for medication effectiveness, though Found users may achieve better long-term maintenance due to behavioral support components. Clinical data is limited for direct platform comparisons, but individual medication efficacy should be similar given equivalent active ingredients.
Customer service quality differs notably between platforms. Hims primarily uses customer service representatives for support, which can result in delays for medical questions requiring physician input. Found's integration of clinical staff and health coaches provides more immediate access to qualified support for both medical and lifestyle concerns.
Choosing between Hims and Found depends primarily on your preferred level of support, budget constraints, and personal approach to weight management. Both platforms can be effective for appropriate patient populations, but they serve distinctly different needs and preferences.
Choose Hims if you: Prefer self-directed weight loss approaches, want the lowest possible medication costs, have straightforward medical history without complex conditions, are comfortable managing side effects independently, and value simplicity over comprehensive support systems.
Choose Found if you: Benefit from structured guidance and accountability, can afford higher monthly costs for comprehensive support, have struggled with weight maintenance in the past, prefer access to specialized obesity medicine physicians, and value behavioral coaching alongside medication treatment.
Patients with limited budgets or those who have successfully managed weight loss independently may find Hims' simplified approach sufficient for their needs. The platform works well for motivated individuals who primarily need medication access without extensive lifestyle intervention.
Found's comprehensive model suits patients who have experienced weight regain after previous diet attempts or those who struggle with emotional eating, portion control, or exercise consistency. The platform's higher cost may be justified for individuals who benefit significantly from professional coaching and behavioral support.
Consider FormBlends as an alternative that combines physician-supervised treatment with competitive pricing and personalized compounding options. Our clinical team provides individualized medication management with transparent pricing and direct physician access.
Neither platform accepts insurance for their service fees, but Found assists patients with insurance claims for brand-name medications when coverage is available. Hims focuses exclusively on cash-pay compounded medications. Most insurance plans don't cover GLP-1 medications for weight loss, though some may cover them for diabetes treatment.
Both platforms typically approve patients within 24-48 hours of completing their consultation. Hims' simplified process may result in slightly faster approval, while Found's more comprehensive evaluation may take an additional day. Medication shipping takes 3-7 business days for both platforms.
Hims provides customer service support and physician consultation for side effect management, though response times may vary. Found offers immediate access to health coaches and scheduled physician consultations for side effect evaluation and treatment adjustments. Both platforms can modify dosing or switch medications as needed.
Yes, patients can discontinue either service and switch to alternative providers. However, neither platform offers refunds for unused portions of monthly subscriptions. You'll need a new consultation and prescription from your chosen platform, as prescriptions cannot be transferred between telehealth services.
Compounded medications contain the same active ingredients as brand-name versions but are prepared in smaller batches by specialized pharmacies. While they should have equivalent efficacy, some patients report differences in side effect profiles or effectiveness. Clinical research specifically comparing compounded versus brand-name GLP-1 medications is limited.
Both Hims and Found offer legitimate pathways to GLP-1 medication access, but your choice should align with your support needs, budget, and personal preferences for medical oversight. Consider your past experiences with weight loss attempts, current medical complexity, and long-term maintenance goals when evaluating these platforms.
If you're seeking a middle-ground approach that combines physician supervision with competitive pricing, consider exploring FormBlends' personalized weight loss programs. Our physician-supervised telehealth clinic offers individualized treatment plans with transparent pricing and direct access to medical professionals who specialize in metabolic health and weight management.
Take our free assessment to determine if GLP-1 medications are appropriate for your weight loss goals and discover personalized treatment options that fit your lifestyle and budget.
1. Hims & Hers Health, Inc. Weight Loss Treatment Options. Accessed March 2026. https://www.hims.com/weight-loss
2. Found Health Inc. Weight Loss Program Details. Accessed March 2026. https://www.found.health
3. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216.
5. FDA. Compounding and the FDA: Questions and Answers. Updated 2024. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
6. American Board of Obesity Medicine. Physician Certification Requirements. Accessed March 2026. https://www.abom.org
This article is for informational purposes only and does not constitute medical advice. GLP-1 medications may cause serious side effects and are not appropriate for all patients. Consult with a qualified healthcare provider before starting any weight loss treatment. Individual results may vary, and no outcomes are guaranteed. Always follow your physician's guidance regarding medication use, dosing, and monitoring requirements.
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided has been reviewed by licensed healthcare professionals but should not replace a consultation with your physician. Individual results vary. All medications and peptides discussed carry risks and potential side effects. Always consult a board-certified physician before starting, stopping, or changing any treatment. FormBlends provides physician-supervised telehealth services; all prescriptions require physician approval based on individual medical evaluation.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are reviewed by licensed physicians but are not a substitute for a personal medical consultation.
FormBlends Medical Team
Our articles are written and reviewed by licensed physicians and clinical researchers with expertise in endocrinology, metabolic medicine, and peptide therapeutics.
Ready to get started?
Physician-supervised GLP-1 and peptide therapy, delivered to your door.
Start Your ConsultationCompare Hims and Found Weight Loss GLP-1 programs for 2026. Review medication options, coaching support, pricing, and clinical approach to choose the right platform.
Provider ComparisonsCompare Hims, Ro, and Found GLP-1 platforms. Detailed analysis of pricing, medications, physician oversight, and value to help you choose the best option.
Provider ComparisonsAn honest comparison of MEDVi and Hims GLP-1 weight loss programs in 2026. Pricing, medications, provider access, and which platform fits your needs.
Provider ComparisonsMEDVi vs Found Weight Loss comparison. Side-by-side review of these GLP-1 weight loss programs.
Provider ComparisonsHims vs Hers comparison. Side-by-side review of these GLP-1 weight loss programs.
Provider ComparisonsHims vs Ro Body comparison. Side-by-side review of these GLP-1 weight loss programs.
GLP-1 & Peptide Expert
Hi! I'm your GLP-1 & peptide expert.
Ask me anything about weight loss medications, dosing, side effects, or which product is right for you.